Back of the Napkin Bios

Back of the Napkin Bios

STVN: The Compounder Quietly Doing What Compounders Do

The Headline Numbers are Good but the Subtext is Better.

Back of the Napkin Bios's avatar
Back of the Napkin Bios
Mar 04, 2026
∙ Paid

The original mandate of my original post was simple: find businesses that compound quietly (particularly during an inflection), expand margins predictably, and reward patience. Stevanato Group just reported fiscal year 2025 results, and it’s a reminder of why STVN belongs in that category.

Full-year revenue grew 7% (9% at constant currency) to €1.186 billion. Adjusted EBITDA margin expanded 160 basis points to 25.1%. Adjusted diluted EPS grew 13% to €0.54. None of those numbers are going to break the internet but it’s important to look underneath them.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 Back of the Napkin Bios · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture